B
Barbara Fisher
Researcher at University of Western Ontario
Publications - 119
Citations - 30412
Barbara Fisher is an academic researcher from University of Western Ontario. The author has contributed to research in topics: Radiation therapy & Temozolomide. The author has an hindex of 40, co-authored 116 publications receiving 26509 citations. Previous affiliations of Barbara Fisher include London Health Sciences Centre & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Radiotherapy for pediatric central nervous system tumors: a regional cancer centre experience.
Glenn Bauman,Barbara Fisher,Elizabeth Cairney,Adriana Ranger,A. Rashid Dar,Jill Ross,Larry Stitt,David W. Macdonald +7 more
TL;DR: Results of this retrospective review of pediatric patients treated at a regional cancer center for primary CNS tumors (other than low grade glioma) were comparable to contemporary results reported by other Canadian centers and North American co-operative group trials.
Journal ArticleDOI
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma
Jessica Fleming,Stephanie L. Pugh,Barbara Fisher,Glenn J. Lesser,David R. Macdonald,Erica Hlavin Bell,Joseph P. McElroy,Aline Paixão Becker,Cynthia D Timmers,Kenneth Aldape,C. Leland Rogers,Thomas J. Doyle,Maria Werner-Wasik,Jean-Paul Bahary,Hsiang-Hsuan Michael Yu,David D'Souza,Nadia N. Laack,Penny K. Sneed,Young Kwok,Minhee Won,Minesh P. Mehta,Arnab Chakravarti +21 more
TL;DR: In this paper, the prognostic significance of the WHO-defined glioma molecular subgroups along with additional alterations, including MGMT promoter methylation and mutations, was determined.
Journal ArticleDOI
Predictors of radiotherapy-related gastrointestinal toxicity from anal cancer DP-IMRT: Secondary analysis of RTOG 0529.
Jeffrey R. Olsen,Jennifer Moughan,Robert J. Myerson,A.A. Abitbol,Charles A. Kunos,Douglas B. Johnson,Tracey E. Schefter,Yuhchyau Chen,Barbara Fisher,Jeff M. Michalski,Samir Narayan,Albert J. Chang,Christopher H. Crane,Lisa A. Kachnic +13 more
TL;DR: This secondary analysis was performed to identify patient (pt) and treatment factors associated with acute and late gastrointestinal (GI) adverse events (AEs) associated with dose-painted intensity-modulated radiation therapy (DP-IMRT).
Journal ArticleDOI
Use of Protoporphyrin Fluorescence to Determine Clinical Target Volume Margins for Nonmelanotic Skin Cancers Treated With Primary Radiation Therapy
TL;DR: Longer follow-up with larger pools of patients are necessary to determine if using PpIX photo-delineation translates into significantly improved clinical outcomes.
Journal ArticleDOI
Use of Protoporphyrin Fluorescence to Determine Clinical Target Volume for Non-melanotic Skin Cancers Treated with Primary Radiotherapy.
Stephanie Casey,Lara Best,O. Vujovic,Kevin Jordan,Barbara Fisher,Deborah Carey,Deborah Bourdeau,Edward Yu +7 more
TL;DR: The margins currently used to account for subclinical disease may underestimate the extent of microscopic spread for poorly demarcated tumors, and longer follow-up with larger pools of patients are necessary to determine if using PpIX photo-delineation translates into significantly improved clinical outcomes.